RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - Restatement on the consolidated statement of operations, the consolidated balance and the consolidated statement of cash flows - USD ($)	3 Months Ended	12 Months Ended
	Aug. 31, 2020	May 31, 2021
Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of sales	$ 960,930
Gross Profit	182,876
Operating Expenses:
Selling, general and administrative	1,164,564
Research and development	674,693
Total operating expense	1,839,257
Loss from operations	(1,656,381)
Loss before income taxes	(1,648,290)
Net loss	$ (1,649,415)
Basic net loss per common share (in Dollars per share)	$ (0.14)
Diluted net loss per common share (in Dollars per share)	$ (0.14)
Comprehensive loss	$ (1,651,136)
Shareholders' Equity:
Additional Paid-in-capital		$ 36,685,176
Accumulated deficit		(28,394,768)
Other Equity accounts		936,615
Total Shareholders' Equity		9,227,023
Cash flows from operating activities:
Net loss	(1,649,415)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock option expense	3,808
Net cash used in operating activities	(1,597,146)
Cash and cash equivalents at end of period	6,964,314
Revision of Prior Period, Error Correction, Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of sales	64,787
Gross Profit	(64,787)
Operating Expenses:
Selling, general and administrative	141,380
Research and development	36,812
Total operating expense	178,192
Loss from operations	(242,979)
Loss before income taxes	(242,979)
Net loss	$ (242,979)
Basic net loss per common share (in Dollars per share)	$ (0.02)
Diluted net loss per common share (in Dollars per share)	$ (0.02)
Comprehensive loss	$ (242,979)
Shareholders' Equity:
Additional Paid-in-capital		2,151,567
Accumulated deficit		(2,151,567)
Other Equity accounts
Total Shareholders' Equity
Cash flows from operating activities:
Net loss	(242,979)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock option expense	242,979
Net cash used in operating activities
Cash and cash equivalents at end of period
Restatement Of Companys Financial Statements [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of sales	1,025,717
Gross Profit	118,089
Operating Expenses:
Selling, general and administrative	1,305,944
Research and development	711,505
Total operating expense	2,017,449
Loss from operations	(1,899,360)
Loss before income taxes	(1,891,269)
Net loss	$ (1,892,394)
Basic net loss per common share (in Dollars per share)	$ (0.16)
Diluted net loss per common share (in Dollars per share)	$ (0.16)
Comprehensive loss	$ (1,894,115)
Shareholders' Equity:
Additional Paid-in-capital		38,836,743
Accumulated deficit		(30,546,335)
Other Equity accounts		936,615
Total Shareholders' Equity		$ 9,227,023
Cash flows from operating activities:
Net loss	(1,892,394)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock option expense	246,787
Net cash used in operating activities	(1,597,146)
Cash and cash equivalents at end of period	$ 6,964,314